162 related articles for article (PubMed ID: 27371544)
21. Venous Thromboembolism Prophylaxis in Underweight Hospitalized Patients.
Buckheit D; Lefemine A; Sobieraj DM; Hobbs L
Clin Appl Thromb Hemost; 2021; 27():10760296211018752. PubMed ID: 34080451
[TBL] [Abstract][Full Text] [Related]
22. Low-molecular-weight heparin and unfractionated heparin in prophylaxis against deep vein thrombosis in critically ill patients undergoing major surgery.
De A; Roy P; Garg VK; Pandey NK
Blood Coagul Fibrinolysis; 2010 Jan; 21(1):57-61. PubMed ID: 19844176
[TBL] [Abstract][Full Text] [Related]
23. Choosing the right heparin prophylaxis strategy in medical patients at risk for developing VTE: an evidence-based approach.
Harrington DW
Hosp Pract (1995); 2010 Nov; 38(4):18-28. PubMed ID: 21068523
[TBL] [Abstract][Full Text] [Related]
24. The use of anticoagulants for the treatment and prevention of venous thromboembolism in obese patients: implications for safety.
Ihaddadene R; Carrier M
Expert Opin Drug Saf; 2016 Jan; 15(1):65-74. PubMed ID: 26568174
[TBL] [Abstract][Full Text] [Related]
25. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
[TBL] [Abstract][Full Text] [Related]
26. Assessment of bleeding risk in low-weight patients receiving prophylactic subcutaneous unfractionated heparin.
Jatis AJ; Nei SD; Zieminski JJ; Mara K; Krauter AK
Vasc Med; 2023 Oct; 28(5):443-448. PubMed ID: 37555546
[TBL] [Abstract][Full Text] [Related]
27. European guidelines on perioperative venous thromboembolism prophylaxis: Intensive care.
Duranteau J; Taccone FS; Verhamme P; Ageno W;
Eur J Anaesthesiol; 2018 Feb; 35(2):142-146. PubMed ID: 29112545
[TBL] [Abstract][Full Text] [Related]
28. Early venous thromboembolic event prophylaxis in traumatic brain injury with low-molecular-weight heparin: risks and benefits.
Dudley RR; Aziz I; Bonnici A; Saluja RS; Lamoureux J; Kalmovitch B; Gursahaney A; Razek T; Maleki M; Marcoux J
J Neurotrauma; 2010 Dec; 27(12):2165-72. PubMed ID: 20939698
[TBL] [Abstract][Full Text] [Related]
29. Prophylaxis against venous thromboembolism in hospitalized medically ill patients.
Pendergraft T; Liu X; Edelsberg J; Phatak H; Vera-Llonch M; Liu LZ; Oster G
Circ Cardiovasc Qual Outcomes; 2013 Jan; 6(1):75-82. PubMed ID: 23300270
[TBL] [Abstract][Full Text] [Related]
30. Anti-Xa activity by weight in critically ill patients receiving unfractionated heparin for venous thromboembolism prophylaxis.
Aggarwal MV; Jarrell AS; Gilmore VT; Aboagye JK; Haut ER; Hobson DB; Lau BD; Kickler T; Kraus PS; Shaffer DL; Shermock KM; Streiff MB; Zheng G; Kruer RM
J Crit Care; 2019 Aug; 52():180-185. PubMed ID: 31078999
[TBL] [Abstract][Full Text] [Related]
31. Increased Enoxaparin Dosing for Venous Thromboembolism Prophylaxis in General Trauma Patients.
Walker CK; Sandmann EA; Horyna TJ; Gales MA
Ann Pharmacother; 2017 Apr; 51(4):323-331. PubMed ID: 28228055
[TBL] [Abstract][Full Text] [Related]
32. The Pattern of Heparin Dosing as Venous Thromboembolism Prophylaxis in Adult Underweight Patients Admitted to Critical Care Units at a Tertiary Hospital.
Al Harthy N; Al Harthi F; Al Harb S; Al Dughayem N; Al Harthi K; Gramish J
Cureus; 2022 Nov; 14(11):e31717. PubMed ID: 36569710
[TBL] [Abstract][Full Text] [Related]
33. Enoxaparin versus tinzaparin for venous thromboembolic prophylaxis during rehabilitation after acute spinal cord injury: a retrospective cohort study comparing safety and efficacy.
Marciniak CM; Kaplan J; Welty L; Chen D
PM R; 2012 Jan; 4(1):11-7. PubMed ID: 22269449
[TBL] [Abstract][Full Text] [Related]
34. Predictors and safety of venous thromboembolism prophylaxis among hospitalized inflammatory bowel disease patients.
Ra G; Thanabalan R; Ratneswaran S; Nguyen GC
J Crohns Colitis; 2013 Nov; 7(10):e479-85. PubMed ID: 23537817
[TBL] [Abstract][Full Text] [Related]
35. Hidden Barriers to Delivery of Pharmacological Venous Thromboembolism Prophylaxis: The Role of Nursing Beliefs and Practices.
Elder S; Hobson DB; Rand CS; Streiff MB; Haut ER; Efird LE; Kraus PS; Lehmann CU; Shermock KM
J Patient Saf; 2016 Jun; 12(2):63-8. PubMed ID: 24681420
[TBL] [Abstract][Full Text] [Related]
36. Is low-molecular-weight heparin safe for venous thromboembolism prophylaxis in patients with traumatic brain injury? A Western Trauma Association multicenter study.
Kwiatt ME; Patel MS; Ross SE; Lachant MT; MacNew HG; Ochsner MG; Norwood SH; Speier L; Kozar R; Gerber JA; Rowell S; Krishnakumar S; Livingston DH; Manis G; Haan JM
J Trauma Acute Care Surg; 2012 Sep; 73(3):625-8. PubMed ID: 22929493
[TBL] [Abstract][Full Text] [Related]
37. Venous thromboembolism prophylaxis and clinical consequences in medically ill patients.
Baser O; Liu X; Phatak H; Wang L; Mardekian J; Kawabata H; Petersel D; Hamilton M; Ramacciotti E
Am J Ther; 2013; 20(2):132-42. PubMed ID: 23466619
[TBL] [Abstract][Full Text] [Related]
38. Venous thromboembolism prophylaxis in medically ill patients: a mixed treatment comparison meta-analysis.
Al Yami MS; Silva MA; Donovan JL; Kanaan AO
J Thromb Thrombolysis; 2018 Jan; 45(1):36-47. PubMed ID: 29043538
[TBL] [Abstract][Full Text] [Related]
39. Effect of a dalteparin prophylaxis protocol using anti-factor Xa concentrations on venous thromboembolism in high-risk trauma patients.
Droege ME; Mueller EW; Besl KM; Lemmink JA; Kramer EA; Athota KP; Droege CA; Ernst NE; Keegan SP; Lutomski DM; Hanseman DJ; Robinson BR
J Trauma Acute Care Surg; 2014 Feb; 76(2):450-6. PubMed ID: 24458050
[TBL] [Abstract][Full Text] [Related]
40. The incidence and risk factors of recurrent venous thromboembolism during pregnancy.
Galambosi PJ; Ulander VM; Kaaja RJ
Thromb Res; 2014 Aug; 134(2):240-5. PubMed ID: 24835671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
